Headshot of Desmond Schatz

Medical Director is Author on ADA’s Position Statement

Dr. Desmond Schatz, medical director of the UF Diabetes Institute and past president of medicine & science of the American Diabetes Association (ADA), is the senior author of the ADA’s […]

Decorative image of tools for weight loss
Person injecting insulin
Decorative photo of Dr. Michael Haller.
Prev Next

Recent News

Kenneth Cusi, M.D.

Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction

Jun 15th, 2018

This study evaluated the effects of dulaglutide vs placebo on liver and glycaemic/metabolic measurements in a population with Type 2 diabetes and in a subgroup with non-alcoholic fatty liver/non-alcoholic steatohepatitis.Once-weekly […]

Colorful Syringes

Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.

May 8th, 2018

Dendritic cell (DC) immunotherapy has been effective for prevention of type 1 diabetes (T1D) in NOD mice but fails to protect if initiated after active autoimmunity. As autoreactivity expands inter- and […]

Body Scan

Informational value of percent body fat with body mass index for the risk of abnormal blood glucose: a nationally representative cross-sectional study.

May 7th, 2018

To examine the value of percent body fat (%BF) with body mass index (BMI) to assess the risk of abnormal blood glucose (ABG) among US adults who are normal weight […]

UF Diabetes Institute: “What If”

ECHO Type 1 Diabetes

primary care physician and adult patient

ECHO Type 1 Diabetes is an 18-month pilot program, which is allowing researchers at the University of Florida and Stanford University to learn more about how to improve care access for underserved adult and pediatric communities living with Type 1 Diabetes (T1D).

Read More